Blog Archive

Friday, December 18, 2020

Crash

 Known for obvious reasons as 'the fear index', a drop in the VIX may be a sign of investor overconfidence, while a rapid rise in the VIX could be one of the first indications that a crash is taking place, triggering investors to exit positions en masse.


Generally speaking, crashes usually occur under the following conditions:
a prolonged period of rising stock prices (a bull market) and excessive economic optimism, 
a market where price–earnings ratios exceed long-term averages, and 
extensive use of margin debt and 
leverage by market participants.

A stock on sale

 

When a Stock Goes on Sale 

When it comes to shopping, consumers are always on the lookout for a deal. Black FridayCyber Monday and the Christmas season are prime examples of low prices spurring voracious demand for products. However, for some reason, investors don't get nearly as excited when stocks go on sale. In the stock market, a herd mentality takes over, and investors tend to avoid stocks when prices are low.

Stock trading volume

 Trading volume indicates the number of shares or contracts traded in the market. It tells if a particular price trend is supported by market players. If the price of a share is increasing with higher than normal volume, it indicates investors support the rally and that the stock would continue to move upwards.


IDEX up today 12/18/2020


 

UPDATE: U.S. stock futures pause after Wall Street scores a round of record highs

 

/20

Walgreens plans to administer COVID-19 vaccine to 3 million residents, staff of long-term care facilities

 

Walgreens plans to administer COVID-19 vaccine to 3 million residents, staff of long-term care facilities

Today 7:38 AM ET (MarketWatch)Print

	

(END) Dow Jones Newswires

December 18, 2020 07:38 ET (12:38 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Stock Futures Waver as Stimulus Talks Continue; Shares close at record highs Thursday as lawmakers closed in on a coronavirus relief package

 

Stock Futures Waver as Stimulus Talks Continue; Shares close at record highs Thursday as lawmakers closed in on a coronavirus relief package

Today 6:21 AM ET Editor's PicksPrint
DJ Logo
jeenah moon/Reuters

By Caitlin Ostroff

U.S. stock futures hovered between gains and losses as investors monitored whether Covid-19 infections and worsening economic data would push lawmakers to cement a coronavirus aid package.

Futures tied to the S&P 500 rose 0.1%, suggesting the benchmark stocks gauge will open relatively unchanged after notching another record close Thursday. Futures tied to the technology-focused Nasdaq-100 declined 0.1%.

Top Republicans and Democrats are closing in on a coronavirus relief package that would send direct payments to many Americans, enhance unemployment benefits, provide aid to small businesses and fund distribution of the Covid-19 vaccine, among other measures.

Investors have cheered the prospects of additional fiscal stimulus in recent days as high Covid-19 infections and measures to contain its spread have weighed on the economy. Data released Thursday showed that the number of workers seeking unemployment benefits had reached a three-month high.

"There is clear deterioration in the U.S. economy," said Luca Paolini , chief strategist at Pictet Asset Management . "The market expects fiscal stimulus. There will be a big disappointment if there is no agreement."

In offhours trading, shares in FedEx fell 2.9% after the delivery company beat analyst profit expectations, but said higher revenue was partially offset by increased costs, including from safety equipment to protect workers from Covid-19 .

Tesla's stock could jump in advance of its inclusion in the S&P 500 next week. Dozens of index funds that track the S&P will need to purchase tens of billions of dollars of stock at Friday's closing price to track the index as closely as possible.

Earnings updates are due from Nike and Darden Restaurants , owner of LongHorn Steakhouse and Olive Garden.

Stocks in Asia were mostly lower. The Wall Street Journal reported that U.S. officials were debating how broad to make a list of Chinese companies banned from investment by Americans because of ties to China's military. China's Shanghai Composite Index closed 0.3% lower and Hong Kong's Hang Seng fell 0.7%. Japan's Nikkei 225 index fell 0.2%.

Shares in Semiconductor Manufacturing International Corp . fell 5.2% in Hong Kong trading after the Trump administration added China's largest manufacturer of computing chips to the export blacklist , restricting the company's access to high-end technology.

The pan-continental Stoxx Europe 600 rose 0.1%. Investors were closely watching negotiations between the U.K. and the European Union over a post-Brexit trade deal. Some expect that the British pound could rally further if a deal is reached. European negotiators have said they want a deal by Sunday. Sterling has risen 2.3% this week against a broadly weaker dollar.

"The clock is running down," said Hugh Gimber, a strategist at J.P. Morgan Asset Management .

In bond markets, the yield on 10-year Treasury notes edged up to 0.941% from 0.929% Thursday. Yields rise when prices fall.

Write to Caitlin Ostroff at caitlin.ostroff@wsj.com

MREO

 

  • Mereo BioPharma Group plc (NASDAQ: MREO) rose 31.2% to $2.90 in pre-market trading after the company, and Ultragenyx, reported a license and collaboration agreement for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta.

VTGN plan to buy

 

  • Vistagen Therapeutics Inc (NASDAQ: VTGN) rose 18.8% to $1.10 in pre-market trading after gaining 11% on Thursday. VistaGen priced its 63 million share common stock offering at $0.92 per share.

XELA plan to buy

 

  • Exela Technologies, Inc. (NASDAQ: XELA) rose 70.9% to $0.62 in pre-market trading as the company secured a term loan of $145 million.

40 Stocks Moving in Friday's Pre-Market Session

 

40 Stocks Moving in Friday's Pre-Market Session

Today 7:09 AM ET (Benzinga)Print

Gainers

  • Exela Technologies, Inc. (NASDAQ: XELA) rose 70.9% to $0.62 in pre-market trading as the company secured a term loan of $145 million.
  • Presidio Property Trust, Inc.. (NASDAQ: SQFT) rose 54.1% to $5.70 in pre-market trading after jumping over 26% on Thursday.
  • Cyclo Therapeutics, Inc. (NASDAQ: CYTH) rose 53% to $6.37 in pre-market trading. Cyclo Therapeutics shares jumped 23% on Thursday after Maxim Group initiated coverage on the stock with a Buy rating and a price target of $12 per share.
  • Mereo BioPharma Group plc (NASDAQ: MREO) rose 31.2% to $2.90 in pre-market trading after the company, and Ultragenyx, reported a license and collaboration agreement for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta.
  • DermTech Inc (NASDAQ: DMTK) rose 27.3% to $18.20 in pre-market trading after the company disclosed topline results from TRUST study.
  • Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) rose 24.5% to $9.50 in pre-market trading after the company reported a partnership with Gabriel Science for dental markets.
  • Surface Oncology, Inc. (NASDAQ: SURF) rose 22.2% to $10.40 in pre-market trading. Surface Oncology, on Thursday, announced an agreement for GlaxoSmithKline to exclusively license worldwide development and commercial rights to its preclinical program SRF813, an inhibitory protein expressed on natural killer cells and T cells, for an $85-million upfront payment.
  • Vistagen Therapeutics Inc (NASDAQ: VTGN) rose 18.8% to $1.10 in pre-market trading after gaining 11% on Thursday. VistaGen priced its 63 million share common stock offering at $0.92 per share.
  • Medicenna Therapeutics Corp (NASDAQ: MDNA) rose 18.4% to $4.50 in pre-market trading after Oppenheimer initiated coverage on the stock with an Outperform rating and set a $12 price target.
  • Elys Game Technology Corp (NASDAQ: ELYS) shares rose 15.7% to $4.12 in pre-market trading after declining 9% on Thursday.
  • BioTelemetry, Inc. (NASDAQ: BEAT) rose 15% to $71.00 in pre-market trading after Royal Philips announced plans to buy for $72.00 per share.
  • Jupiter Wellness, Inc. (NASDAQ: JUPW) rose 12.5% to $6.85 in pre-market trading after climbing 15% on Thursday.
  • PainReform Ltd. (NASDAQ: PRFX) shares rose 11.1% to $6.00 in pre-market trading after climbing around 23% on Thursday.
  • TPG Pace Beneficial Finance Corp. (NYSE: TPGY) rose 8.4% to $25.75 in pre-market trading after gaining 15% on Thursday. TPG Pace Beneficial Finance, last week, announced a merger deal with an EV charging company called EVBox.
  • 9 Meters Biopharma, Inc. (NASDAQ: NMTR) shares rose 7.4% to $0.87 in pre-market trading. 9 Meters Biopharma shares climbed over 7% on Thursday after OrbiMed Israel BioFund GP Limited Partnership reported a 16% stake in the company.
  • MicroVision, Inc. (NASDAQ: MVIS) rose 7.4% to $5.36 in pre-market trading after jumping 24% on Thursday.
  • Arbutus Biopharma Corporation (NASDAQ: ABUS) rose 6.8% to $5.05 in pre-market trading. Arbutus Biopharma shares jumped over 7% on Thursday after H.C. Wainwright initiated coverage on the stock with a Buy rating and announced a $10 price target.
  • Artelo Biosciences, Inc. (NASDAQ: ARTL) rose 6.8% to $0.6580 in pre-market trading. Artelo Biosciences, last week, reported filing of patent application for new formulation of ART27.13.
  • Canaan Inc. (NASDAQ: CAN) rose 6.6% to $4.53 in pre-market trading after climbing around 12% on Thursday. Canaan is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment.
  • Uxin Limited (NASDAQ: UXIN) rose 6.3% to $1.18 in pre-market trading. Uxin shares tumbled over 20% on Thursday after the company reported Q2 earnings results.
  • Tattooed Chef, Inc. (NASDAQ: TTCF) shares rose 5.4% to $21.36 in pre-market trading after gaining over 5% on Thursday. Tattooed Chef, last week, reported the expansion of its product range with meat alternatives.
  • Nxt-ID, Inc. (NASDAQ: NXTD) rose 5.3% to $1.50 in pre-market trading after surging over 54% on Thursday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Mesoblast Limited (NASDAQ: MESO) fell 33% to $9.09 in pre-market trading after the company issued an update on COVID-19 ARDS trial. Mesoblast said randomized controlled trial of Remestemcel-L in ventilator-dependent patients with moderate to severe ARDS is not likely to meet 30-day mortality reduction endpoint. Mesoblast, earlier during the week, said results from its Phase 3 trial of Rexlemestrocel-L for advanced chronic heart failure did not meet the primary endpoint.
  • Scopus BioPharma Inc. (NASDAQ: SCPS) fell 26.7% to $24.91 in pre-market trading after climbing 474% on Thursday. Scopus BioPharma’s filing showed registration for 500,000 share common stock offering. Scopus Biopharma priced its IPO at $5.5 per share.
  • Wunong Net Technology Company Limited (NASDAQ: WNW) fell 15.9% to $103.00 in pre-market trading after surging 88% on Thursday. The company, on Tuesday, priced its IPO at $5 per share.
  • Applied DNA Sciences Inc (NASDAQ: APDN) fell 15.7% to $5.26 in pre-market trading after the company reported downbeat quarterly results.
  • MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares fell 14.7% to $14.95 in pre-market trading after jumping 336% on Thursday.
  • Scholastic Corp (NASDAQ: SCHL) fell 12.6% to $23.50 in pre-market trading after reporting downbeat Q2 results.
  • China Liberal Education Holdings Limited (NASDAQ: CLEU) fell 9.8% to $3.78 in pre-market trading. China Liberal Education recently reported sales of 46,626 copies of self-developed textbooks published by Fudan University Press.
  • Oriental Culture Holding LTD (NASDAQ: OCG) fell 9.6% to $6.63 in pre-market trading after gaining 20% on Thursday. Oriental Cultural, on Tuesday, priced its IPO at $4 per share.
  • Vivos Therapeutics, Inc. (NASDAQ: VVOS) fell 8.6% to $8.22 in pre-market trading after gaining 34% on Thursday. Vivos Therapeutics, earlier during the month, priced its IPO at $6 a share.
  • Neovasc Inc. (NASDAQ: NVCN) fell 8.5% to $0.91 in pre-market trading. Neovasc, on Thursday, highlighted publication of peer-reviewed article in EuroIntervention.
  • Steelcase Inc. (NYSE: SCS) fell 7.8% to $12.14 in pre-market trading following downbeat Q3 results.
  • Aethlon Medical, Inc. (NASDAQ: AEMD) fell 7.7% to $2.15 in pre-market trading. Aethlon Medical, earlier during the week, said it treated the first patient in its first-in-human Early Feasibility Study of the HEMOPURIFIER.
  • Greenwich LifeSciences, Inc. (NASDAQ: GLSI) fell 6.8% to $41.51 in pre-market trading after declining around 9% on Thursday. Greenwich LifeSciences recently announced a 470,000 share common stock offering.
  • Virgin Galactic Holdings Inc (NYSE: SPCE) fell 6.4% to $23.86 in pre-market trading after the company filed for a roughly 112.96 million share common stock offering via selling shareholders.
  • BioCardia, Inc. (NASDAQ: BCDA) fell 6.3% to $4.00 in pre-market trading.
  • BioCardia shares tumbled 26% on Thursday after the company announced that the independent Data Safety Monitoring Board has completed its prespecified data review for the Phase III pivotal CardiAMP Heart Failure Trial.
  • United States Steel Corporation (NYSE: X) fell 6.1% to $17.42 in pre-market trading after the company issued weak earnings forecast for the fourth quarter. The company said it sees Q4 adjusted loss of $0.85 per share.
  • Virios Therapeutics, LLC (NASDAQ: VIRI) fell 6% to $15.70 in pre-market trading. Virios Therapeutics shares jumped 67% on Thursday as the company priced its IPO at $10 per share.
  • FedEx Corporation (NYSE: FDX) shares fell 3.2% to $283.00 in pre-market trading. FedEx reported better-than-expected second-quarter results, but did not provide guidance for 2021.

ANGI

 share  12.01   market   2.25  AVG 2.32 (2.95 ) % down  today 0.88%  purchase date  04 April 2024 2.34 3 April 2024 2.48 4 April 2024 2.30

Labels